Table 2

Overview of outcomes in the entire cohort in relation to gestational age, birth weight, gender, and antenatal corticosteroids
Gestational age
240/7 to 246/7 250/7 to 256/7 260/7 to 266/7 270/7 to 276/7 Total
N % N % N % N % N %
Favourable outcome 28 13 76 28 140 40 196 45 440 35
Moderate ND 18 9 36 13 51 15 61 14 166 13
Severe ND 11 5 18 7 21 6 28 6 78 6
Died after delivery room 61 29 90 33 76 22 65 15 292 23
Died in delivery room 87 41 28 10 8 2 7 2 130 10
Survived, no FU 5 2 23 8 50 14 82 19 160 13
Total 210 100 271 100 346 100 439 100 1266 100
Birth weight
< 500g 500-749g 750-999g > 999g Total
N % N % N % N % N %
Favourable outcome 4 9 110 27 211 40 115 42 440 35
Moderate ND 5 11 44 11 82 15 35 13 166 13
Severe ND 1 2 25 6 36 7 16 6 78 6
Died after delivery room 22 49 119 29 112 21 39 14 292 23
Died in delivery room 12 27 83 20 25 5 3 1 123 10
Survived, no FU 1 2 29 7 65 12 65 24 160 13
Total 45 100 410 100 531 100 273 100 1259 100
Sex
female male Total
N % N % N %
Favourable outcome 218 37 222 33 440 35
Moderate ND 75 13 91 13 166 13
Severe ND 29 5 49 7 78 6
Died after delivery room 128 22 164 24 292 23
Died in delivery room 64 11 65 10 129 10
Survived, no FU 71 12 89 13 160 13
Total 585 100 680 100 1265 100
Antenatal corticosteroids
incomplete/none completed Total
N % N % N %
Favourable outcome 140 28 296 41 436 35
Moderate ND 53 10 113 16 166 13
Severe ND 24 5 53 7 77 6
Died after delivery room 139 27 150 21 289 23
Died in delivery room 95 19 16 2 111 9
Survived, no FU 58 11 99 14 157 13
Total 509 100 727 100 1236 10

Died, patient died in NICU or after discharge from the NICU; died in delivery room, patient died in the delivery room; FU, follow-up; ND, neurodevelopmental disability.

Schlapbach et al.

Schlapbach et al. BMC Pediatrics 2012 12:198   doi:10.1186/1471-2431-12-198

Open Data